Albro Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 48 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.66 M
- Revenue Growth 271.26%
- Profit Growth 210.51%
- Ebitda -2685.68%
- Net Worth 17.41%
- Total Assets 132.21%
About Albro Pharmaceuticals
Albro Pharmaceuticals Pvt Ltd (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 May 1976 and has a history of 48 years and eight months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹0.66 M.
Ritesh Rai and Rajinder Singh serve as directors at the Company.
Company Details
-
LocationPunjab, Punjab
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231PB1976PTC003656
-
Company No.
003656
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 May 1976
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Albro Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritesh Rai
|
Director | 20-Apr-2016 | Current |
|
Rajinder Singh
|
Director | 15-Apr-2015 | Current |
Financial Performance of Albro Pharmaceuticals.
Albro Pharmaceuticals Pvt Ltd, for the financial year ended 2020, experienced significant growth in revenue, with a 271.26% increase. The company also saw a substantial improvement in profitability, with a 210.51% increase in profit. The company's net worth Soared by an impressive increase of 17.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Albro Pharmaceuticals?
In 2016, Albro Pharmaceuticals had a promoter holding of 52.50% and a public holding of 47.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lavista Ideal Pharmacy Private LimitedRitesh Rai is a mutual person
-
Lapoo Pharmachem Private Limited
Rajinder Singh is a mutual person
Charges (Loans)
₹0.66 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.06 Cr
- State Bank Of Patiala : 0.01 Cr
- Union Bank Of India : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 1995 | Punjab National Bank | ₹0.36 M | Open |
| 02 Dec 1994 | Punjab National Bank | ₹0.20 M | Open |
| 15 Jun 1983 | State Bank Of Patiala | ₹0.08 M | Open |
| 12 Mar 1981 | Union Bank Of India | ₹0.03 M | Open |
How Many Employees Work at Albro Pharmaceuticals?
Unlock and access historical data on people associated with Albro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albro Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
